Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 235

1.

Trait Conscientiousness predicts rate of brain atrophy in multiple sclerosis.

Fuchs TA, Benedict RH, Wilding G, Wojcik C, Jakimovski D, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Zivadinov R, Dwyer MG.

Mult Scler. 2019 Jun 20:1352458519858605. doi: 10.1177/1352458519858605. [Epub ahead of print]

PMID:
31219390
2.

Perceived Neuropsychological Impairment Inversely Related to Self-reported Health and Employment in Multiple Sclerosis.

D'hooghe MB, De Cock A, Benedict RHB, Gielen J, Van Remoortel A, Eelen P, Van Merhaegen A, De Keyser J, D'haeseleer M, Peeters E, Nagels G.

Eur J Neurol. 2019 Jun 10. doi: 10.1111/ene.14012. [Epub ahead of print]

PMID:
31183915
3.

Cognitive Profiles of Aging in Multiple Sclerosis.

Jakimovski D, Weinstock-Guttman B, Roy S, Jaworski M 3rd, Hancock L, Nizinski A, Srinivasan P, Fuchs TA, Szigeti K, Zivadinov R, Benedict RHB.

Front Aging Neurosci. 2019 May 10;11:105. doi: 10.3389/fnagi.2019.00105. eCollection 2019.

4.

Epidemiology and treatment of multiple sclerosis in elderly populations.

Vaughn CB, Jakimovski D, Kavak KS, Ramanathan M, Benedict RHB, Zivadinov R, Weinstock-Guttman B.

Nat Rev Neurol. 2019 Jun;15(6):329-342. doi: 10.1038/s41582-019-0183-3. Review.

PMID:
31000816
5.

Lower total cerebral arterial flow contributes to cognitive performance in multiple sclerosis patients.

Jakimovski D, Benedict RH, Marr K, Gandhi S, Bergsland N, Weinstock-Guttman B, Zivadinov R.

Mult Scler. 2019 Jan 9:1352458518819608. doi: 10.1177/1352458518819608. [Epub ahead of print]

PMID:
30625030
6.

Trait Conscientiousness predicts rate of longitudinal SDMT decline in multiple sclerosis.

Fuchs TA, Wojcik C, Wilding GE, Pol J, Dwyer MG, Weinstock-Guttman B, Zivadinov R, Benedict RH.

Mult Scler. 2019 Jan 7:1352458518820272. doi: 10.1177/1352458518820272. [Epub ahead of print]

PMID:
30615562
7.

Health risk prediction models incorporating personality data: Motivation, challenges, and illustration.

Chapman BP, Lin F, Roy S, Benedict RHB, Lyness JM.

Personal Disord. 2019 Jan;10(1):46-58. doi: 10.1037/per0000300.

PMID:
30604983
8.

Dalfampridine benefits ambulation but not cognition in multiple sclerosis.

Satchidanand N, Drake A, Smerbeck A, Hojnacki D, Kolb C, Patrick K, Weinstock-Guttman B, Motl R, Benedict RH.

Mult Scler. 2018 Dec 19:1352458518815795. doi: 10.1177/1352458518815795. [Epub ahead of print]

PMID:
30566030
9.

Fatigue at enrollment predicts EDSS worsening in the New York State Multiple Sclerosis Consortium.

Vaughn CB, Kavak KS, Dwyer MG, Bushra A, Nadeem M, Cookfair DL, Ramanathan M, Benedict RH, Zivadinov R, Goodman A, Krupp L, Motl RW, Weinstock-Guttman B; New York State Multiple Sclerosis Consortium.

Mult Scler. 2018 Dec 3:1352458518816619. doi: 10.1177/1352458518816619. [Epub ahead of print]

PMID:
30507270
10.

Necessity of technicians for computerized neuropsychological assessment devices in multiple sclerosis.

Wojcik CM, Rao SM, Schembri AJ, Drake AS, Maruff P, Schindler D, Alberts J, Yasin F, Pol J, Weinstock-Guttman B, Benedict RH.

Mult Scler. 2018 Nov 22:1352458518813287. doi: 10.1177/1352458518813287. [Epub ahead of print]

PMID:
30465463
11.

Lower self-report fatigue in multiple sclerosis is associated with localized white matter tract disruption between amygdala, temporal pole, insula, and other connected structures.

Fuchs TA, Vaughn CB, Benedict RHB, Weinstock-Guttman B, Choudhery S, Carolus K, Rooney P, Ashton K, P Ramasamy D, Jakimovski D, Zivadinov R, Dwyer MG.

Mult Scler Relat Disord. 2019 Jan;27:298-304. doi: 10.1016/j.msard.2018.11.005. Epub 2018 Nov 9.

PMID:
30453198
12.

Symbol Digit Modalities Test: A valid clinical trial endpoint for measuring cognition in multiple sclerosis.

Strober L, DeLuca J, Benedict RH, Jacobs A, Cohen JA, Chiaravalloti N, Hudson LD, Rudick RA, LaRocca NG; Multiple Sclerosis Outcome Assessments Consortium (MSOAC).

Mult Scler. 2018 Oct 18:1352458518808204. doi: 10.1177/1352458518808204. [Epub ahead of print]

PMID:
30334474
13.

Recommendations for cognitive screening and management in multiple sclerosis care.

Kalb R, Beier M, Benedict RH, Charvet L, Costello K, Feinstein A, Gingold J, Goverover Y, Halper J, Harris C, Kostich L, Krupp L, Lathi E, LaRocca N, Thrower B, DeLuca J.

Mult Scler. 2018 Nov;24(13):1665-1680. doi: 10.1177/1352458518803785. Epub 2018 Oct 10.

14.

Integrative CNS Plasticity With Exercise in MS: The PRIMERS (PRocessing, Integration of Multisensory Exercise-Related Stimuli) Conceptual Framework.

Sandroff BM, Motl RW, Reed WR, Barbey AK, Benedict RHB, DeLuca J.

Neurorehabil Neural Repair. 2018 Oct;32(10):847-862. doi: 10.1177/1545968318798938. Epub 2018 Sep 12.

PMID:
30205784
15.

Walking disability measures in multiple sclerosis patients: Correlations with MRI-derived global and microstructural damage.

Jakimovski D, Weinstock-Guttman B, Hagemeier J, Vaughn CB, Kavak KS, Gandhi S, Bennett SE, Fuchs TA, Bergsland N, Dwyer MG, Benedict RHB, Zivadinov R.

J Neurol Sci. 2018 Oct 15;393:128-134. doi: 10.1016/j.jns.2018.08.020. Epub 2018 Aug 23.

PMID:
30165291
16.

Importance of Balance-Gait Disorder as a Risk Factor for Cognitive Impairment, Dementia and Related Non-Motor Symptoms in Parkinson's Disease.

Lichter DG, Benedict RHB, Hershey LA.

J Parkinsons Dis. 2018;8(4):539-552. doi: 10.3233/JPD-181375.

PMID:
30124451
17.

Hypertension and heart disease are associated with development of brain atrophy in multiple sclerosis: a 5-year longitudinal study.

Jakimovski D, Gandhi S, Paunkoski I, Bergsland N, Hagemeier J, Ramasamy DP, Hojnacki D, Kolb C, Benedict RHB, Weinstock-Guttman B, Zivadinov R.

Eur J Neurol. 2019 Jan;26(1):87-e8. doi: 10.1111/ene.13769. Epub 2018 Sep 3.

PMID:
30103277
18.

Separate and Combined Influence of Cognitive Impairment and Dysarthria on Functional Communication in Multiple Sclerosis.

Feenaughty L, Tjaden K, Weinstock-Guttman B, Benedict RHB.

Am J Speech Lang Pathol. 2018 Aug 6;27(3):1051-1065. doi: 10.1044/2018_AJSLP-17-0174.

19.

A decline in cognitive function should lead to a change in disease-modifying therapy - Yes.

Weinstock-Guttman B, Eckert S, Benedict RH.

Mult Scler. 2018 Nov;24(13):1681-1682. doi: 10.1177/1352458518783364. Epub 2018 Jul 16. No abstract available.

PMID:
30010476
20.

Altered nuclei-specific thalamic functional connectivity patterns in multiple sclerosis and their associations with fatigue and cognition.

Lin F, Zivadinov R, Hagemeier J, Weinstock-Guttman B, Vaughn C, Gandhi S, Jakimovski D, Hulst HE, Benedict RH, Bergsland N, Fuchs T, Dwyer MG.

Mult Scler. 2018 Jul 1:1352458518788218. doi: 10.1177/1352458518788218. [Epub ahead of print]

PMID:
30004291
21.

Impact of Focal White Matter Damage on Localized Subcortical Gray Matter Atrophy in Multiple Sclerosis: A 5-Year Study.

Fuchs TA, Carolus K, Benedict RHB, Bergsland N, Ramasamy D, Jakimovski D, Weinstock-Guttman B, Kuceyeski A, Zivadinov R, Dwyer MG.

AJNR Am J Neuroradiol. 2018 Aug;39(8):1480-1486. doi: 10.3174/ajnr.A5720. Epub 2018 Jul 5.

PMID:
29976833
22.

Thalamic white matter in multiple sclerosis: A combined diffusion-tensor imaging and quantitative susceptibility mapping study.

Bergsland N, Schweser F, Dwyer MG, Weinstock-Guttman B, Benedict RHB, Zivadinov R.

Hum Brain Mapp. 2018 Oct;39(10):4007-4017. doi: 10.1002/hbm.24227. Epub 2018 Jun 19.

PMID:
29923266
23.

Odorant Item Specific Olfactory Identification Deficit May Differentiate Alzheimer Disease From Aging.

Woodward MR, Hafeez MU, Qi Q, Riaz A, Benedict RHB, Yan L, Szigeti K; Texas Alzheimer's Research, Care Consortium.

Am J Geriatr Psychiatry. 2018 Aug;26(8):835-846. doi: 10.1016/j.jagp.2018.02.008. Epub 2018 Apr 19.

PMID:
29858162
24.

White matter tract network disruption explains reduced conscientiousness in multiple sclerosis.

Fuchs TA, Dwyer MG, Kuceyeski A, Choudhery S, Carolus K, Li X, Mallory M, Weinstock-Guttman B, Jakimovski D, Ramasamy D, Zivadinov R, Benedict RHB.

Hum Brain Mapp. 2018 May 8. doi: 10.1002/hbm.24203. [Epub ahead of print]

PMID:
29740964
25.

Preliminary investigation of cognitive function in aged multiple sclerosis patients: Challenges in detecting comorbid Alzheimer's disease.

Roy S, Drake A, Snyder S, Cline B, Khan A, Fuchs T, Zivadinov R, Weinstock-Guttman B, Szigeti K, Benedict RHB.

Mult Scler Relat Disord. 2018 May;22:52-56. doi: 10.1016/j.msard.2018.03.008. Epub 2018 Mar 13.

PMID:
29574353
26.

Longitudinal personality change associated with cognitive decline in multiple sclerosis.

Roy S, Drake A, Fuchs T, Dwyer MG, Zivadinov R, Chapman BP, Weinstock-Guttman B, Benedict RH.

Mult Scler. 2018 Jan 1:1352458517753720. doi: 10.1177/1352458517753720. [Epub ahead of print]

PMID:
29363385
27.

Improved cognitive performance and event-related potential changes following working memory training in patients with multiple sclerosis.

Covey TJ, Shucard JL, Benedict RH, Weinstock-Guttman B, Shucard DW.

Mult Scler J Exp Transl Clin. 2018 Jan 11;4(1):2055217317747626. doi: 10.1177/2055217317747626. eCollection 2018 Jan-Mar.

28.

Neuropsychology of Multiple Sclerosis: Looking Back and Moving Forward.

Benedict RHB, DeLuca J, Enzinger C, Geurts JJG, Krupp LB, Rao SM.

J Int Neuropsychol Soc. 2017 Oct;23(9-10):832-842. doi: 10.1017/S1355617717000959. Review.

PMID:
29198279
29.

Influence of nationality on the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).

Smerbeck A, Benedict RHB, Eshaghi A, Vanotti S, Spedo C, Blahova Dusankova J, Sahraian MA, Marques VD, Langdon D.

Clin Neuropsychol. 2018 Jan;32(1):54-62. doi: 10.1080/13854046.2017.1354071. Epub 2017 Jul 19.

PMID:
28721748
30.

Olfactory identification deficit predicts white matter tract impairment in Alzheimer's disease.

Woodward MR, Dwyer MG, Bergsland N, Hagemeier J, Zivadinov R, Benedict RH, Szigeti K.

Psychiatry Res Neuroimaging. 2017 Aug 30;266:90-95. doi: 10.1016/j.pscychresns.2017.06.004. Epub 2017 Jun 9.

31.

Apolipoprotein E genotype impact on memory and attention in older persons: the moderating role of personality phenotype.

Chapman BP, Benedict RHB, Lin F, Roy S, Porteinsson A, Szigeti K, Federoff H, Mapstone M.

Int J Geriatr Psychiatry. 2018 Feb;33(2):332-339. doi: 10.1002/gps.4748. Epub 2017 Jun 14.

PMID:
28612377
32.

Improved cognitive outcomes in patients with relapsing-remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE study.

Benedict RH, Cohan S, Lynch SG, Riester K, Wang P, Castro-Borrero W, Elkins J, Sabatella G.

Mult Scler. 2018 May;24(6):795-804. doi: 10.1177/1352458517707345. Epub 2017 May 9.

33.

Personality and Performance in Specific Neurocognitive Domains Among Older Persons.

Chapman BP, Benedict RH, Lin F, Roy S, Federoff HJ, Mapstone M.

Am J Geriatr Psychiatry. 2017 Aug;25(8):900-908. doi: 10.1016/j.jagp.2017.03.006. Epub 2017 Apr 3.

34.

Trait neuroticism, extraversion, and conscientiousness in multiple sclerosis: Link to cognitive impairment?

Roy S, Drake AS, Eizaguirre MB, Zivadinov R, Weinstock-Guttman B, Chapman BP, Benedict RH.

Mult Scler. 2018 Feb;24(2):205-213. doi: 10.1177/1352458517695467. Epub 2017 Feb 1.

PMID:
28273781
35.

Remote assessment of verbal memory in MS patients using the California Verbal Learning Test.

Barcellos LF, Bellesis KH, Shen L, Shao X, Chinn T, Frndak S, Drake A, Bakshi N, Marcus J, Schaefer C, Benedict RH.

Mult Scler. 2018 Mar;24(3):354-357. doi: 10.1177/1352458517694087. Epub 2017 Feb 1.

36.

Validation of olfactory deficit as a biomarker of Alzheimer disease.

Woodward MR, Amrutkar CV, Shah HC, Benedict RH, Rajakrishnan S, Doody RS, Yan L, Szigeti K.

Neurol Clin Pract. 2017 Feb;7(1):5-14. doi: 10.1212/CPJ.0000000000000293.

37.

Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis.

Benedict RH, DeLuca J, Phillips G, LaRocca N, Hudson LD, Rudick R; Multiple Sclerosis Outcome Assessments Consortium.

Mult Scler. 2017 Apr;23(5):721-733. doi: 10.1177/1352458517690821. Epub 2017 Feb 16.

38.

Brain MRI atrophy quantification in MS: From methods to clinical application.

Rocca MA, Battaglini M, Benedict RH, De Stefano N, Geurts JJ, Henry RG, Horsfield MA, Jenkinson M, Pagani E, Filippi M.

Neurology. 2017 Jan 24;88(4):403-413. doi: 10.1212/WNL.0000000000003542. Epub 2016 Dec 16. Review.

39.

Differential effects of aging on motor and cognitive functioning in multiple sclerosis.

Roy S, Frndak S, Drake AS, Irwin L, Zivadinov R, Weinstock-Guttman B, Benedict RH.

Mult Scler. 2017 Sep;23(10):1385-1393. doi: 10.1177/1352458516679036. Epub 2016 Nov 25.

PMID:
27885064
40.

Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach.

Uher T, Vaneckova M, Sormani MP, Krasensky J, Sobisek L, Dusankova JB, Seidl Z, Havrdova E, Kalincik T, Benedict RH, Horakova D.

Eur J Neurol. 2017 Feb;24(2):292-301. doi: 10.1111/ene.13200. Epub 2016 Nov 22.

PMID:
27873386
41.

Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: A retrospective, pilot, observational longitudinal study.

Zivadinov R, Ramasamy DP, Vaneckova M, Gandhi S, Chandra A, Hagemeier J, Bergsland N, Polak P, Benedict RH, Hojnacki D, Weinstock-Guttman B.

Mult Scler. 2017 Sep;23(10):1336-1345. doi: 10.1177/1352458516678083. Epub 2016 Nov 4.

PMID:
27811339
42.

Synergistic Effects of Reserve and Adaptive Personality in Multiple Sclerosis.

Roy S, Schwartz CE, Duberstein P, Dwyer MG, Zivadinov R, Bergsland N, Powell V, Weinstock-Guttman B, Benedict RH.

J Int Neuropsychol Soc. 2016 Oct;22(9):920-927. Epub 2016 May 6.

PMID:
27151620
43.

Executive Function and Personality Predict Instrumental Activities of Daily Living in Alzheimer Disease.

Roy S, Ficarro S, Duberstein P, Chapman BP, Dubovsky S, Paroski M, Szigeti K, Benedict RHB.

Am J Geriatr Psychiatry. 2016 Nov;24(11):1074-1083. doi: 10.1016/j.jagp.2016.06.014. Epub 2016 Jul 4.

44.

A new assessment tool for patients with multiple sclerosis from Spanish-speaking countries: validation of the Brief International Cognitive Assessment for MS (BICAMS) in Argentina.

Vanotti S, Smerbeck A, Benedict RH, Caceres F.

Clin Neuropsychol. 2016 Oct;30(7):1023-31. doi: 10.1080/13854046.2016.1184317. Epub 2016 May 12.

PMID:
27668977
45.

Latent profile analysis of regression-based norms demonstrates relationship of compounding MS symptom burden and negative work events.

Frndak SE, Smerbeck AM, Irwin LN, Drake AS, Kordovski VM, Kunker KA, Khan AL, Benedict RH.

Clin Neuropsychol. 2016 Oct;30(7):1050-62. doi: 10.1080/13854046.2016.1200144. Epub 2016 Jun 21.

PMID:
27326756
46.

Regression-Based Norms for the Brief Visuospatial Memory Test-Revised in Italian population and application in MS patients.

Argento O, Smerbeck A, Pisani V, Magistrale G, Incerti CC, Caltagirone C, Benedict RH, Nocentini U.

Clin Neuropsychol. 2016 Jan-Dec;30(sup1):1469-1478. Epub 2016 May 13.

PMID:
27174449
47.

Benchmarks of meaningful impairment on the MSFC and BICAMS.

Benedict RH, Drake AS, Irwin LN, Frndak SE, Kunker KA, Khan AL, Kordovski VM, Motl RW, Weinstock-Guttman B.

Mult Scler. 2016 Dec;22(14):1874-1882. Epub 2016 Feb 26.

PMID:
26920379
48.

Aging and multiple sclerosis.

Sanai SA, Saini V, Benedict RH, Zivadinov R, Teter BE, Ramanathan M, Weinstock-Guttman B.

Mult Scler. 2016 May;22(6):717-25. doi: 10.1177/1352458516634871. Epub 2016 Feb 19. Review.

PMID:
26895718
49.

Autoimmune Comorbidities Are Associated with Brain Injury in Multiple Sclerosis.

Zivadinov R, Raj B, Ramanathan M, Teter B, Durfee J, Dwyer MG, Bergsland N, Kolb C, Hojnacki D, Benedict RH, Weinstock-Guttman B.

AJNR Am J Neuroradiol. 2016 Jun;37(6):1010-6. doi: 10.3174/ajnr.A4681. Epub 2016 Feb 18.

50.

Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis.

Roy S, Benedict RH, Drake AS, Weinstock-Guttman B.

CNS Drugs. 2016 Mar;30(3):209-25. doi: 10.1007/s40263-016-0319-6. Review.

PMID:
26884145

Supplemental Content

Loading ...
Support Center